Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | Taxol | 0.1 | uM | 10 | 156.25 | 67.09 | 78.67 | 263.25 | 0.3811 | 0.1487 |
| MDA-MB-231 | Taxol | 0.31623 | uM | 10 | 156.25 | 67.09 | 86.67 | 263.25 | 0.3600 | 0.1078 |
| MDA-MB-231 | Taxol | 1 | uM | 10 | 156.25 | 67.09 | 76.00 | 263.25 | 0.3394 | 0.0750 |
| MDA-MB-231 | Linsitinib | 0.0033113 | uM | 10 | 156.25 | 67.09 | 304.67 | 209.92 | 1.4288 | 1.4461 |
| MDA-MB-231 | Linsitinib | 0.01 | uM | 10 | 156.25 | 67.09 | 206.00 | 209.92 | 0.9813 | 0.9765 |
| MDA-MB-231 | Linsitinib | 0.031623 | uM | 10 | 156.25 | 67.09 | 201.33 | 209.92 | 0.9574 | 0.9356 |
| MDA-MB-231 | Linsitinib | 0.1 | uM | 10 | 156.25 | 67.09 | 280.67 | 209.92 | 1.3292 | 1.3596 |
| MDA-MB-231 | Linsitinib | 0.31623 | uM | 10 | 156.25 | 67.09 | 242.67 | 209.92 | 1.1406 | 1.1390 |
| MDA-MB-231 | Linsitinib | 1 | uM | 10 | 156.25 | 67.09 | 255.00 | 209.92 | 1.1889 | 1.1718 |
| MDA-MB-231 | Linsitinib | 3.1623 | uM | 10 | 156.25 | 67.09 | 240.33 | 209.92 | 1.1333 | 1.1351 |
| MDA-MB-231 | Linsitinib | 10 | uM | 10 | 156.25 | 67.09 | 156.00 | 209.92 | 0.7337 | 0.6399 |
| MDA-MB-231 | Linsitinib | 19.9526 | uM | 10 | 156.25 | 67.09 | 105.67 | 209.92 | 0.4946 | 0.2823 |
| MDA-MB-231 | Palbociclib | 0.0033113 | uM | 10 | 156.25 | 67.09 | 275.67 | 263.25 | 1.0634 | 1.0283 |
| MDA-MB-231 | Palbociclib | 0.01 | uM | 10 | 156.25 | 67.09 | 271.67 | 263.25 | 1.0409 | 1.0249 |
| MDA-MB-231 | Palbociclib | 0.031623 | uM | 10 | 156.25 | 67.09 | 258.00 | 263.25 | 1.0728 | 1.2177 |
| MDA-MB-231 | Palbociclib | 0.1 | uM | 10 | 156.25 | 67.09 | 205.67 | 263.25 | 0.8041 | 0.7510 |
| MDA-MB-231 | Palbociclib | 0.31623 | uM | 10 | 156.25 | 67.09 | 167.67 | 263.25 | 0.6456 | 0.5340 |
| MDA-MB-231 | Palbociclib | 1 | uM | 10 | 156.25 | 67.09 | 114.00 | 263.25 | 0.4365 | 0.2185 |
| MDA-MB-231 | Palbociclib | 3.1623 | uM | 10 | 156.25 | 67.09 | 93.33 | 263.25 | 0.3690 | 0.1170 |
| MDA-MB-231 | Palbociclib | 10 | uM | 10 | 156.25 | 67.09 | 90.67 | 263.25 | 0.3587 | 0.1024 |
| MDA-MB-231 | Palbociclib | 19.9526 | uM | 10 | 156.25 | 67.09 | 109.00 | 263.25 | 0.4873 | 0.3525 |
| MDA-MB-231 | 17-AAG | 0.0016596 | uM | 10 | 312.50 | 120.45 | 568.67 | 523.75 | 1.0922 | 1.0866 |
| MDA-MB-231 | 17-AAG | 0.0033113 | uM | 10 | 312.50 | 120.45 | 547.67 | 523.75 | 1.0380 | 1.0267 |
| MDA-MB-231 | 17-AAG | 0.01 | uM | 10 | 312.50 | 120.45 | 710.00 | 523.75 | 1.3467 | 1.2844 |
| MDA-MB-231 | 17-AAG | 0.031623 | uM | 10 | 312.50 | 120.45 | 663.33 | 523.75 | 1.2739 | 1.2331 |